Yunker Energy & Health Herbal Supplement Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Sato Pharmaceutical Inc. is recalling Yunker Energy & Health Herbal Supplement because the product does not meet label claim for Vitamin E.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on July 9, 2026 and geographically references United States. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, food.
What Happened
Sato Pharmaceutical Inc. initiated a voluntary recall of Yunker(branded) Energy & Health Herbal Supplement with Vitamins because the product does not meet label claim for Vitamin E.
Which Products Are Affected
The recall covers Yunker(branded) Energy & Health Herbal Supplement with Vitamins manufactured by Sato Pharmaceuticals Co. Ltd. in 30ml containers. Products are packed as single serving (UPC: 49873-916-11), 3 units/pack (UPC: 49873-916-15), and 10 units per pack (UPC: 49873-916-07). A total of 25,130 units across all package sizes are affected. Affected lots include: single CXW T (Jan-27), 3pack CXW T (Jan-27), 10pack PXW Z (Mar-26), and 10pack XXW W (Dec-27). The product was distributed nationwide.
What You Should Do
Consumers should check the lot and expiration codes on purchased products. Contact information for returns or refunds was not provided in the recall notice.
Why This Matters
The recall involves 25,130 units distributed nationwide and is classified as Class III.
Source
FDA recall number H-0892-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,065 characters here).
Similar severity timing
Same severity (low) notices issued closest in time to July 9, 2026.
Frequently Asked Questions
Common questions about this FDA recall.